BeStock  
Stocks › Biotechnology › TVTX

Travere Therapeutic TVTX

US equityMarket cap rank #2128Biotechnology
$47.00 −$1.30 (-2.69%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $47.29 +0.62%
Open$48.09
Prev close$48.30
Day range$46.90 – $49.35
Volume1.33M
Market cap$4.51B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-39.0x
CheapRich

Near the bottom of its 5-year range · 15th percentile, 5-year average -29.7x

Price / book215.5x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average 30.6x

#5315 of 5331 stocks by PB (1 = cheapest)

Price / sales7.5x
CheapRich

Above its usual level · 71st percentile, 5-year average 6.3x

#4308 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-286x-174x-61x52xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$43.98
Price vs. fair value+6.9%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 215.53 – 30.56 96% (pricier than usual) #5315 of 5331 (1 = cheapest)
PE -38.96 17.21 -29.66 15% (cheaper than usual) –
PS 7.47 4.45 6.28 71% (pricier than usual) #4308 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on TVTX.

Sign in to join the discussion.

Scroll to Top